• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用来曲唑作为 GnRH 激动剂抑制后的 transgender 青春期少女的辅助刺激手段,成功进行卵母细胞冷冻保存。

Successful oocyte cryopreservation using letrozole as an adjunct to stimulation in a transgender adolescent after GnRH agonist suppression.

机构信息

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Washington University in Saint Louis, Saint Louis, Missouri.

Division of Endocrinology and Diabetes, Department of Pediatrics, Washington University in Saint Louis, Saint Louis, Missouri.

出版信息

Fertil Steril. 2021 Aug;116(2):522-527. doi: 10.1016/j.fertnstert.2021.02.025. Epub 2021 Mar 29.

DOI:10.1016/j.fertnstert.2021.02.025
PMID:33795140
Abstract

OBJECTIVE

To report a successful case of ovarian hyperstimulation and oocyte cryopreservation in a transgender male adolescent after suppression with a gonadotropin-releasing hormone (GnRH) agonist while using the aromatase inhibitor letrozole to maintain low serum estradiol.

DESIGN

Case report.

SETTING

Division of Reproductive Endocrinology and Infertility, Washington University in St. Louis School of Medicine, St Louis, Missouri.

PATIENT(S): A 15-year-old Tanner II transgender male adolescent with a GnRH agonist implant.

INTERVENTION(S): The GnRH agonist implant was removed. The patient was given letrozole (5 mg daily) while undergoing ovarian stimulation with an antagonist protocol. After oocyte retrieval, the patient began taking testosterone.

MAIN OUTCOME MEASURE(S): Successful oocyte cryopreservation with minimal changes in breast budding.

RESULT(S): The patient's peak serum estradiol concentration was 510 pg/mL. Twenty-two mature oocytes were cryopreserved. Small increases in breast budding occurred between baseline and the time of oocyte retrieval.

CONCLUSION(S): We successfully used letrozole to maintain low serum estradiol in a transgender male adolescent during ovarian stimulation. Maintaining low estradiol to minimize pubertal development and possibly prevent gender dysphoria symptoms may make oocyte cryopreservation more desirable for transgender male adolescents.

摘要

目的

报告 1 例 GnRH 激动剂抑制下使用芳香化酶抑制剂来曲唑维持低血清雌二醇水平,对跨性别男性青少年进行卵巢刺激和卵母细胞冷冻保存的成功案例。

设计

病例报告。

地点

密苏里州圣路易斯华盛顿大学医学院生殖内分泌与不孕不育科。

患者

15 岁,Ⅱ期 Tanner 跨性别男性青少年,使用 GnRH 激动剂植入物。

干预

取出 GnRH 激动剂植入物。患者接受拮抗剂方案的卵巢刺激时,给予来曲唑(每天 5 毫克)。取卵后,患者开始服用睾酮。

主要观察指标

卵母细胞冷冻保存成功,乳房发育变化最小。

结果

患者血清雌二醇浓度峰值为 510 pg/ml。冷冻保存了 22 个成熟卵母细胞。在取卵前,乳房发育略有增加。

结论

我们成功地在 GnRH 激动剂抑制下使用来曲唑维持跨性别男性青少年的低血清雌二醇水平。维持低雌二醇以最大限度地减少青春期发育,并可能预防性别焦虑症状,可能使卵母细胞冷冻保存更受跨性别男性青少年的欢迎。

相似文献

1
Successful oocyte cryopreservation using letrozole as an adjunct to stimulation in a transgender adolescent after GnRH agonist suppression.使用来曲唑作为 GnRH 激动剂抑制后的 transgender 青春期少女的辅助刺激手段,成功进行卵母细胞冷冻保存。
Fertil Steril. 2021 Aug;116(2):522-527. doi: 10.1016/j.fertnstert.2021.02.025. Epub 2021 Mar 29.
2
Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing ovarian stimulation for fertility preservation.促性腺激素释放激素激动剂触发可增加癌症患者进行生育力保存的卵巢刺激中可用于冷冻保存的卵母细胞和胚胎数量。
Fertil Steril. 2017 Sep;108(3):532-538. doi: 10.1016/j.fertnstert.2017.06.027.
3
[Efficacy analysis of letrozole combined with gonadotropin-releasing hormone antagonists in patients with high risk of ovarian hyperstimulation syndrome undergoing total embryo freezing].来曲唑联合促性腺激素释放激素拮抗剂在接受全胚冷冻的卵巢过度刺激综合征高危患者中的疗效分析
Zhonghua Yi Xue Za Zhi. 2024 Aug 6;104(30):2823-2829. doi: 10.3760/cma.j.cn112137-20240107-00044.
4
Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients.来曲唑相关的控制性卵巢刺激用于乳腺癌患者生育力保存时的孕酮水平
Hum Reprod. 2015 Sep;30(9):2184-9. doi: 10.1093/humrep/dev155. Epub 2015 Jun 24.
5
Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist.双重触发促进最终卵母细胞成熟可提高对促性腺激素释放激素激动剂反应欠佳者的卵母细胞采集率。
Fertil Steril. 2016 Nov;106(6):1356-1362. doi: 10.1016/j.fertnstert.2016.07.1068. Epub 2016 Aug 1.
6
[Letrozole versus gonadotropin-releasing hormone antagonist during luteal phase in the prevention of ovarian hyperstimulation syndrome: a randomized controlled trial].来曲唑与促性腺激素释放激素拮抗剂在黄体期预防卵巢过度刺激综合征中的比较:一项随机对照试验
Zhonghua Fu Chan Ke Za Zhi. 2020 Jan 25;55(1):9-14. doi: 10.3760/cma.j.issn.0529-567X.2020.01.003.
7
Suboptimal response to GnRH-agonist trigger during oocyte cryopreservation: a case series.促性腺激素释放激素激动剂扳机时机对卵母细胞冷冻保存反应不佳:病例系列。
Reprod Biol Endocrinol. 2020 Jun 5;18(1):59. doi: 10.1186/s12958-020-00614-y.
8
Which is the optimal timing for starting chemoprotection with gonadotropin-releasing hormone agonists after oocyte cryopreservation? Reflections on a critical case of ovarian hyperstimulation syndrome.卵母细胞冷冻保存后,使用促性腺激素释放激素激动剂开始化学保护的最佳时机是什么?关于一例严重卵巢过度刺激综合征病例的思考。
J Gynecol Obstet Hum Reprod. 2021 Apr;50(4):101815. doi: 10.1016/j.jogoh.2020.101815. Epub 2020 Jun 17.
9
The use of GnRH-agonist trigger for the final maturation of oocytes in normal and low responders undergoing planned oocyte cryopreservation.在计划进行卵母细胞冷冻保存的正常和低反应者中,使用 GnRH 激动剂触发剂进行卵母细胞的最终成熟。
Hum Reprod. 2020 May 1;35(5):1054-1060. doi: 10.1093/humrep/deaa042.
10
Effect of letrozole on moderate and severe early-onset ovarian hyperstimulation syndrome in high-risk women: a prospective randomized trial.来曲唑对高危女性中重度早发性卵巢过度刺激综合征的影响:一项前瞻性随机试验
Am J Obstet Gynecol. 2017 Jan;216(1):42.e1-42.e10. doi: 10.1016/j.ajog.2016.08.018. Epub 2016 Aug 20.

引用本文的文献

1
Ovarian response and outcomes of in vitro fertilization cycles in transgender men: Report of three cases with a live birth.transgender男性体外受精周期的卵巢反应及结局:三例活产报告
JBRA Assist Reprod. 2025 Apr 30;29(2):394-8. doi: 10.5935/1518-0557.20240114.
2
Clinical and ethical perspectives of ovarian stimulation and oocyte cryopreservation in adolescents: 6 years experience from a tertiary centre.青少年卵巢刺激和卵母细胞冷冻保存的临床与伦理视角:来自三级中心的6年经验
Hum Reprod Open. 2025 Jan 24;2025(1):hoaf005. doi: 10.1093/hropen/hoaf005. eCollection 2025.
3
Clinical management of transgender and non-binary patients in the fertility preservation service: Current evidence.
生育力保存服务中跨性别和非二元性别人群患者的临床管理:当前证据
Int J Transgend Health. 2023 Nov 24;25(4):663-680. doi: 10.1080/26895269.2023.2284775. eCollection 2024.
4
Reproductive Health in Trans and Gender Diverse Patients: Effects of transmasculine gender-affirming hormone therapy on future reproductive capacity: clinical data, animal models, and gaps in knowledge.跨性别和性别多样化患者的生殖健康:跨男性性别肯定激素治疗对未来生殖能力的影响:临床数据、动物模型和知识空白。
Reproduction. 2024 Oct 3;168(5). doi: 10.1530/REP-24-0163. Print 2024 Nov 1.
5
Fertility counseling guide for transgender and gender diverse people.跨性别者和性别多元者的生育咨询指南。
Int J Transgend Health. 2023 Sep 12;24(4):361-367. doi: 10.1080/26895269.2023.2257062. eCollection 2023.
6
Preservation of Fertility in Transgender Men on Long-Term Testosterone Therapy: A Systematic Review of Oocyte Retrieval Outcomes During and After Exogenous Androgen Exposure.长期接受睾酮治疗的跨性别男性的生育力保存:对外源性雄激素暴露期间及之后卵母细胞采集结果的系统评价
Transgend Health. 2023 Oct 4;8(5):408-419. doi: 10.1089/trgh.2022.0023. eCollection 2023 Oct.
7
In vitro fertilization outcomes in a mouse model of gender-affirming hormone therapy in transmasculine youth.在跨性别男性青年的性别肯定激素治疗的小鼠模型中进行的体外受精结果。
F S Sci. 2023 Nov;4(4):302-310. doi: 10.1016/j.xfss.2023.08.001. Epub 2023 Aug 12.
8
Ovarian stimulation and oocyte cryopreservation in females and transgender males aged 18 years or less: a systematic review.18 岁及以下女性和跨性别男性的卵巢刺激和卵母细胞冷冻保存:系统评价。
Front Endocrinol (Lausanne). 2023 Jun 19;14:1146476. doi: 10.3389/fendo.2023.1146476. eCollection 2023.
9
Fertility preservation in pediatric healthcare: a review.儿科保健中的生育力保存:综述。
Front Endocrinol (Lausanne). 2023 May 3;14:1147898. doi: 10.3389/fendo.2023.1147898. eCollection 2023.
10
Fertility, Contraception, and Fertility Preservation in Trans Individuals.跨性别者的生育力、避孕和生育力保存。
Dtsch Arztebl Int. 2023 Apr 7;120(14):243-250. doi: 10.3238/arztebl.m2023.0026.